Exercise and health check study for older colorectal cancer patients
Part of Brain & nervous system, Cancer, Digestive system, Ear, nose & throat clinical trials.
This trial looks at sarcopenia (loss of muscle strength/size) and vertigo (feeling dizzy or off-balance) in older adults with colorectal cancer. It tests whether a structured, exercise-based approach can help these issues alongside cancer care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 65 or older when you sign consent.
- You are scheduled for neoadjuvant, adjuvant, or first-line palliative chemotherapy for colorectal cancer.
- You can read and speak Danish, and you can sign the study consent form.
- Your general ability to do daily activities is limited but not too much (ECOG score 0–2).
- You do not have major recent chemotherapy in the last 2 years and you do not have ongoing severe dizziness/vertigo or balance problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at why cancer can cause loss of muscle in people with advanced non–small cell lung cancer, and whether exercise can improve or explain those muscle changes. You may be asked to do physical testing and answer questionnaires while receiving standard palliative cancer treatment.
This study tests whether exercise and mental exercises can help older cancer survivors who notice memory or thinking problems. You'll take part in a program that combines physical activity with brain training to see if it improves your day-to-day life.
This trial tests whether a supervised exercise and brain-training program can improve memory and thinking skills in older people after cancer treatment. It may help if you’re noticing thinking or memory problems since finishing curative cancer care.
This study looks at how chemotherapy and immunotherapy affect the body in older adults with colorectal cancer, especially early side effects. It may help researchers understand why some people lose strength and how to better predict and manage treatment toxicity.
This trial studies whether supervised exercise—either aerobic fitness training or muscle-strength training—can improve outcomes for people with metastatic colorectal cancer. It compares which approach is most helpful and checks whether it’s safe during first-line chemotherapy.
This study tests if a supervised exercise program can improve how well older adults can walk, keep their balance, and feel mentally well. You would attend exercise sessions three times a week for 12 weeks.
Hear when a new Colorectal cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.